Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watkins, B. A.
Right arrow Articles by Seifert, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watkins, B. A.
Right arrow Articles by Seifert, M. F.

The Journal of Nutrition Vol. 127 No. 6 June 1997, pp. 1084-1091
Copyright ©1997 by the American Society for Nutritional Sciences

Dietary Lipids Modulate Bone Prostaglandin E2 Production, Insulin-Like Growth Factor-I Concentration and Formation Rate in Chicks1,2

Bruce A. Watkins3, Chwan-L. Shen, John P. McMurtry*, Hui Xu, Steven D. Baindagger , Kenneth G. D. Allen**, and Mark F. SeifertDagger

Department of Food Science, Lipid Chemistry and Metabolism Laboratory, Purdue University, West Lafayette, IN 47907-1160; * USDA, Growth Biology Laboratory, Livestock and Poultry Institute, Beltsville, MD 20705; dagger  ZymoGenetics, Inc., Seattle, WA 98105; ** Department of Food Science and Human Nutrition, Colorado State University, Ft. Collins, CO 80523; and Dagger  Department of Anatomy, Indiana University Medical Center, Indianapolis, IN 46202

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
ACKNOWLEDGMENTS
FOOTNOTES
LITERATURE CITED

ABSTRACT

This study examined the effects of dietary fat on the fatty acid composition of liver and bone, and on the concentration of insulin-like growth factor-I (IGF-I) in liver and bone, as well as the relationship of these factors to bone metabolism. Day-old male broiler chicks were given a semipurified diet containing one of four lipid sources: soybean oil (SBO), butter + corn oil (BC), margarine + corn oil (MAC), or menhaden oil + corn oil (MEC) at 70 g/kg of the diet. At 21 and 42 d of age, chicks fed MEC had the highest concentration of (n-3) fatty acids [20:5(n-3), 22:5(n-3) and 22:6(n-3)] in polar and neutral lipids of cortical bone but the lowest amount of 20:4(n-6) in polar lipids. Diets containing t-18:1 fatty acids (MAC and BC) resulted in t18:1 accumulation in bone and liver. Bone IGF-I concentration increased from 21 to 42 d in chicks given the SBO and BC diets. Tibial periosteal bone formation rate (BFR) was higher in chicks given BC compared with those consuming SBO and MEC at 21 d. The higher BFR and concentrations of hexosamine in serum and IGF-I in cartilage, but lower 20:4(n-6) content in bone polar lipids in chicks given BC compared with those given SBO suggest that BC optimized bone formation by altering the production of bone growth factors. A second study confirmed that dietary butter fat lowered ex vivo prostaglandin E2 production and increased trabecular BFR in chick tibia. These studies showed that dietary fat altered BFR perhaps by controlling the production of local regulatory factors in bone.

KEY WORDS: lipids · bone · prostaglandin E2 · insulin-like growth factor-I · chicks

INTRODUCTION

The importance of prostaglandin E2 (PGE2 )4 in bone biology was realized with the discovery that this derivative of (n-6) polyunsaturated fatty acids (PUFA) caused resorption of bone mineral and the release of calcium into bone organ culture (Klein and Raisz 1970). Since then, considerable clinical and experimental evidence has revealed that PG are potent stimulators of bone formation (Marks and Miller 1993, Norrdin et al. 1990, Raisz 1993). The PG are believed to mediate part of the anabolic effects of biomechanical forces (Chow and Chambers 1994), parathyroid hormone (Yang et al. 1987), cytokines (Raisz 1993), and insulin-like growth factors (IGF ) (Baylink et al. 1993, McCarthy and Centrella 1993) in bone. Even though PGE2 was reported to increase metaphyseal and cortical bone mass of growing animals (Marks and Miller 1993), the response may be concentration dependent (Raisz and Fall 1990). On the other hand, excess inflammatory production of PGE might contribute to bone pathology, as in osteomyelitis and avian osteopetrosis (Norrdin et al. 1990).

Bone tissue and cells produce IGF (Isgaard 1992, McCarthy and Centrella 1993), and appreciable amounts of IGF-I and IGF-II are stored in skeletal tissue of vertebrates, including chickens and humans (Bautista et al. 1990). Although the concentration of IGF-I in bone is lower than that of IGF-II, IGF-I appears to be under greater regulatory control (Canalis et al. 1991, McCarthy et al. 1991).

Prostaglandin E2 was reported to increase IGF-I transcript and polypeptide levels in rat calvaria cells (McCarthy et al. 1991, Schmid et al. 1992) and stimulate the expression of mRNA for IGF binding protein-3 (BP-3) to enhance the IGFBP-3 binding affinity to rat calvaria (Schmid et al. 1992). Thus, some of the effects exerted by PGE2 on bone formation/resorption may be mediated locally by inducing the biosynthesis of IGF-I. Recent studies on bone modeling in chicks demonstrated that diets enriched with saturated fat or vitamin E stimulated bone formation (Xu et al. 1995). In addition, diets enriched with (n-6) PUFA elevated ex vivo bone PGE2 production and lowered the rate of trabecular bone formation (Watkins et al. 1996).

At this time it is unclear how dietary PUFA can influence endogenous PGE2 production and bone formation. Therefore, the present study was designed to evaluate the effects of dietary lipids, varying in amounts of (n-3) and (n-6) PUFA, saturated and trans-18:1 fatty acids, on the fatty acid composition of chick bone tissue and to ascertain if the concentration of 20:4(n-6), the precursor of PGE2 , is modulated in bone by dietary lipids. Histomorphometry was performed to quantify static and dynamic events of bone modeling, and IGF-I was measured to determine the effects of the treatments on the concentration of this growth factor produced in bone.

MATERIALS AND METHODS

Animals and diets. Hubbard cockerel broiler chicks (160 d-old, average body weight, 41 g) were purchased from a local hatchery (Fairview Farm, Remington, IN). Animal care was in compliance with applicable guidelines for the policy on animal care and use at Purdue University. The chicks were individually wing-banded, weighed and randomly placed in temperature-controlled battery brooders on continuous light. Each treatment group contained four replicate pens of 10 chicks. The chicks were fed a basal semipurified diet (Table 1) containing one of the following dietary lipid treatments (70 g/kg diet): soybean oil (SBO); butter (52 g) + corn oil (18 g) (BC); margarine (55 g) + corn oil (15 g) (MAC); or menhaden oil (40 g) + corn oil (30 g) (MEC). The dietary ingredients were purchased (Dyets, Bethlehem, PA) or donated (ME Zapata Haynie, Reedville, VA). The addition of corn oil was made to the butter, margarine and menhaden oil treatments to supplement the essential fatty acid [18:2(n-6)] content of those diets. The semi-purified diet (Table 1) was formulated to meet or exceed the nutrient requirements of the growing chick (NRC 1994). Chicks were given free access to food and water throughout the 56-d feeding period. The diet containing MEC was kept at 4°C until fed, and fresh diet was provided every 24 h. Body weights and feed consumptions were recorded weekly to determine weight gains and feed conversions (total g gain/total g feed consumed). In a second study, day-old Hubbard cockerel broiler chicks (16 per treatment group) were fed for 16 d the basal diet containing SBO or anhydrous butter oil (ABO, Level Valley Dairy, West Bend, WI) at 100 g/kg. The amounts of cornstarch and dextrose were reduced by 15 g/kg to accommodate the extra fat. The higher level of dietary fat was used to better represent the amount of fat energy contained in a human diet, and ABO was selected as the saturated fat source because it is the fat found in milk and, unlike butter, it is free of food additives.

Table 1. Fatty acid composition and ingredient composition of the chick basal diet1,2,3

[View Table]

Sample collections. Two chicks per pen (eight per treatment) were used for bone histomorphometric measurements and tissue analyses at 21 and 42 d of age. At 5 and 3 d before killing, chicks were injected intraperitoneally with calcein green (15 mg/kg body weight) to label mineralizing bone surfaces. On d 21 and 42, chicks were killed by exsanguination. Tibia bones were excised, freed of surrounding soft tissue and their lengths measured with a vernier caliper. A 3 to 5-cm thick section of cortical bone was cut from the mid-diaphysis of the right tibia with a low speed diamond wheel saw (Model 11-1180, Buehler, Evanston, IL), fixed in 70% ethyl alcohol, and processed undecalcified for bone histomorphometry. In the second study, tissue samples were collected from chicks at 16 d. Right tibia bones were processed undecalcified for histomorphometry (Watkins et al. 1996), and livers and left tibia were collected and samples either kept on ice and frozen at -20°C for lipid and fatty acid analyses or immersed in liquid nitrogen and stored at -80°C for IGF-I analysis.

Blood was collected by cardiac puncture at 14, 28, 42 and 56 d of age. Blood containing EDTA (2 g EDTA/L blood) was centrifuged at 1000 × g for 20 min to obtain plasma and stored at -80°C for later IGF-I analysis. Hematocrits were determined on blood collected from the wing vein of chicks.

Analytical procedures. Histomorphometric analyses were performed on cross sections of tibia cortical bone (Watkins et al. 1989) or on frontal sections of proximal tibia bone in the second study (Watkins et al. 1996). Lipids in liver and tibia cortical bone were extracted with chloroform/methanol (2:1, v/v). Cortical bone, freed of periosteum and marrow, was cooled with liquid nitrogen and pulverized to a fine powder with a mortar and pestle, placed in 7 mL methanol and sonicated for 10 min prior to the extraction of lipids. Polar (phospholipids) and neutral (triacylglycerols) lipids in cortical bone and liver were isolated by solid-phase extraction (Hamilton and Comai 1988). Fatty acid methyl esters (FAME) from lipid fractions were prepared by transesterification using 14% BF3 in methanol. The FAME were extracted in isooctane for gas-liquid chromatographic (GLC) analysis by an HP 5890A gas chromatograph equipped with a flame ionization detector, autosampler, and workstation (Hewlett-Packard, Avondale, PA). A DB 23 (50% cyanopropyl-50% methyl) fused silica capillary column (30 m × 0.25 mm i.d., J & W Scientific, Rancho Cordova, CA) was used with helium as the carrier gas. The initial oven temperature of 175°C was held for 10 min and increased at a rate of 1°C/min until the final temperature of 210°C was reached and held for 5 min. The total time of gas chromatographic analysis was 50 min. An external standard mixture prepared from known amounts of triacylglycerols and methylated fatty acids (Nu Check-Prep, Elysian, MN) was used to obtain retention times and to develop the calibration table. Retention times for 18:4(n-3), 20:5(n-3) and 22:5(n-3) were obtained from the analysis of menhaden oil.

Total cis and trans isomers of 18:1 were determined by combined GLC and argentation-TLC as previously described (Watkins et al. 1991). The isomers of 18:1 eluted from 8.3 to 8.9 min. The reported values for 18:1 fatty acids in the diets and tissues included all positional and geometric isomers.

Fatty acid composition of the diets and tissue samples was expressed as mol/100 mol of FAME in the lipids. The amounts of total saturated fatty acids (SAT), monounsaturated fatty acids (MONO), PUFA, total (n-6) and (n-3) PUFA, and the (n-3):(n-6) ratios were calculated from the GLC analyses.

Plasma IGF-I levels were determined as previously described (Ballard et al. 1990). 125I-labeled-IGF-I tracer was obtained from Amersham (Arlington, IL), and the primary antibody (rabbit anti-bovine IGF-I) was kindly provided by G. Francis (CSIRO, Adelaide, Australia). Human sequence IGF-I (GROPEP, Adelaide, Australia) was employed as the standard. Tissue IGF-I concentrations were determined following the method of McMurtry et al. (1994).

Plasma, liver and muscle hemoglobin concentrations were measured (Morrison 1965), and hemoglobin values were used to correct for the analyzed concentrations of IGF-I in those tissues. Liver and muscle protein concentrations were determined with a bicinchoninic acid protein assay kit purchased from Pierce (Rockford, IL) using bovine serum albumin as the standard. The values for IGF-I were expressed as nanograms or micrograms of IGF-I per milligram protein, except for bone.

Other analytical procedures included the measurement of hexosamine concentrations in bone and serum (Boas 1953), employing glycocyamine hydrochloride as the standard. Plasma vitamin E was extracted with ethanol (20 mg BHT/L) as described by MacCrehan (1990) and tocopherols quantified (Pascoe et al. 1987) by HPLC using a reversed-phase C18 column and electrochemical detector. Separation was achieved by isocratically eluting with 96% methanol and 4% 50 mmol/L NaCIO4 at a flow rate of 1 mL/min and comparing peaks with known tocopherol standards (Sigma Chemical, St Louis, MO). The activity of phospholipase A2 (PLA2 ) in serum and liver cytosol preparations from chicks at 42 d was measured by RIA (Glaser and Jacobs 1986) using dl-alpha -phosphatidyl-cholinedipalmitoyl as a substrate in the presence of 5 mmol/L CaCl2 . For bone ash and calcium concentration, samples of tibia bone were dried, weighed, dry-ashed at 600°C for 48 h, and ash content calculated by weight loss on a dry basis (Watkins et al. 1996). The dried bone was digested with 15.9 mol/L HNO3 and calcium concentration (mmol/g) measured by atomic absorption spectroscopy (Model 2380 Perkin-Elmer, Norwalk, CT). Ex vivo PGE2 production was quantified in tibia bone organ culture from 16-d-old chicks fed SBO or ABO (Watkins et al. 1996).

Data analyses. Data were statistically analyzed by a one-way or two-way ANOVA, and significant differences between treatment means were tested using Student-Newman-Keuls test at the 5% probability level (Neter and Wasserman 1974). Variation within treatments was expressed as the SEM, pooled SD for unequal sample size or pooled SEM for equal sample size.

RESULTS

The fatty acid composition of the four diets presented in Table 1 indicated that the SBO diet provided the highest amounts of 18:2(n-6) and 18:3(n-3), and the MEC diet contained the greatest levels of 16:1(n-7), 20:5(n-3), 22:5(n-3) and 22:6(n-3). The BC diet was highest in 14:0, 16:0, and saturates, and the MAC diet contained the largest amount of trans-18:1. Total PUFA and (n-6) fatty acid levels were greatest in the SBO diet, but the total amount of (n-3) fatty acids and the ratio of (n-3):(n-6) PUFA were highest in the MEC diet. Based on the GLC analysis, the semipurified diets provided an adequate amount of 18:2(n-6) (12-35 g/kg of diet) for the growing chick, an amount well above the required 10 g/kg of diet (NRC 1994).

There was no significant difference (P > 0.05) in feed conversions for chicks at 42 d across the dietary treatments (mean values ranged from 0.69 to 0.72). The growth rates of chicks did not differ among diet groups and the mean body weights at 42 d (mean values ranged from 1280 to 1450 g) were not significantly different (P > 0.05).

The fatty acid composition of polar and neutral lipids in tibial cortical bone of chicks at 21 d presented in Table 2 showed significant differences between dietary treatments. Chicks fed the SBO diet had higher concentrations of 18:2(n-6), 20:4(n-6), 22:4(n-6) and total (n-6) PUFA in bone polar lipids compared with those fed the MEC diet. Chicks fed the MEC diet had the lowest concentration of 20:4(n-6) in bone polar lipids but the highest concentrations of 20:5(n-3), 22:5(n-3), 22:6(n-3), total (n-3) PUFA and ratio of (n-3):(n-6) PUFA in bone polar and neutral lipids. The concentration of 20:4(n-6) in bone polar lipids was lower in the BC group compared with the SBO group. The concentration of total MONO was highest in bone polar lipids, and the concentrations of 18:1 and total MONO were greatest in neutral lipids of chicks fed the BC and MAC diets. The neutral lipids in bone of chicks fed the BC diet had the highest amounts of 14:0, 15:0, 16:0, and total SAT but the lowest amounts of 18:2(n-6) and total (n-6) PUFA.

Table 2. Fatty acid composition of polar lipids and neutral lipids isolated from proximal tibiotarsal cortical bone of 21-d-old chicks fed different lipids1

[View Table]

The fatty acid composition of polar and neutral lipids in cortical bone of chicks at 42 d (data not shown) were consistent with the results from 21 d. Those given the MEC diet maintained the lowest concentration of 20:4(n-6) in polar lipids but the highest amounts of (n-3) PUFA [20:5(n-3), 22:5(n-3), and 22:6(n-3)] in bone polar and neutral lipids at 42 d. The concentrations of 20:(4n-6) and total (n-6) PUFA decreased in bone polar lipids for chicks given the SBO diet from 21 to 42 d. Consistent with the data from chicks at 21 d was the trend for a higher concentration of 18:1 and MONO in bone lipids of those given the BC and MAC diets. The amount of trans-18:1 in bone was higher in chicks given the MAC diet (6.7% in polar and 11.2% in neutral lipids) than in those given the BC diet (1.5% in polar and a trace amount in neutral lipids).

The proportion of SAT/MONO/PUFA in bone neutral lipids of chicks fed the BC treatment was 2.86:3.1:1.0 and 2.61:2.43:1.0 at 21 and 42 d, respectively. In contrast, these proportions were 1.2:1.3:1.0 at 21 d and 0.97:1.06:1.0 at 42 d in bone neutral lipids of chicks in the SBO group. The proportion of SAT/MONO/PUFA in the polar lipid fraction was 0.96:0.48:1.0 and 0.65:0.21:1.0 for the BC and SBO groups at 21 d, respectively. However, the ratios were similar for the two treatment groups at 42 d. These ratios reflect a greater proportion of (n-6) PUFA to SAT and MONO in bone lipids of chicks given SBO.

Consumption of the MEC diet also elevated the (n-3) PUFA in polar and neutral lipids in liver of chicks as illustrated in Figure 1 at 21 and 42 d (data not shown). The values for fatty acids are presented as standardized differences (STD) based on statistical analysis (number of standard error of the mean units). The STD values for (n-6) and (n-3) PUFA of chicks given the MEC diet show that 20:4(n-6) and total (n-6) PUFA were decreased in polar lipids, but 20:5(n-3), 22:6(n-3) and total (n-3) PUFA were increased in neutral and polar lipids compared with chicks given the other treatments. The liver polar lipids of chicks given the BC diet had the highest amount of 18:1 at 21 d, but those fed BC and MEC had the lowest amount of 18:2(n-6) at 21 and 42 d. The amount of trans-18:1 was highest in liver of chicks fed the MAC diet (5.8% in polar and neutral lipids), and a trace amount was present in liver of those consuming the BC diet (0.8% in polar and neutral lipids).

Fig. 1. Liver fatty acid values presented as standardized differences (STD) for polar lipids (panel A) and neutral lipids (panel B) in 21-d-old chicks. The STD for fatty acid values were calculated as a difference in treatment mean [butter + corn oil (BC), margarine + corn oil (MAC), or menhaden oil + corn oil (MEC)] from the mean for those given soybean oil (SBO) divided by the pooled SEM (n = 4). Bars having a * are significantly different than the SBO treatment (P < 0.05).
[View Larger Version of this Image (24K GIF file)]

Histomorphometric data on cortical bone modeling in the tibia revealed that the BC diet increased the bone formation rate (BFR) in chicks at 21 d (Table 3). Higher values for periosteal BFR (mm2/d), total new BFR (mm2/d) and intracortical porosity (mm2) were observed in chicks fed the BC diet compared with values in chicks given the SBO and MEC diets. The values for total bone area (mm2) and cortical bone area (mm2) were lowest in chicks fed the SBO diet. There were no differences in values for cortical bone width (mm), periosteal mineral apposition rate (MAR) (µm/d), percentage of cortical bone, and percentage of medullary cavity among the diet groups. Chick tibia bone length was not influenced (P > 0.05) by the dietary treatments at 21 d (Table 3) or 42 d (lengths ranged from 111.8 to 113.6 mm). The histomorphometric values were not significantly different in chicks at 42 d (P > 0.05), and the periosteal BFR and MAR in the tibia ranged from 0.029 to 0.054 mm2/d and 0.031 to 0.039 µm/d, respectively.

Table 3. Bone length and histomorphometric measurements in the tibia of 21-d-old chicks fed different lipids1

[View Table]

The plasma levels of IGF-I (µg/L) in chicks given the dietary treatments increased from 14 to 56 d (P < 0.05) (Fig. 2). At 14 d of age, the plasma concentration of IGF-I was highest (P < 0.05) in chicks consuming the MEC diet (23.3 µg/L). Plasma IGF-I concentration in chicks given the MEC diet was 138% of that measured in chicks fed the SBO diet. The level of IGF-I in plasma significantly increased in chicks fed the SBO, BC and MAC diets from 14 to 28 d of age but not in those given the MEC diet. The concentration of IGF-I in plasma was greatest (30.1 µg/L) (P < 0.05) in 28-d-old chicks given the MAC diet. There were no significant treatment differences in plasma IGF-I concentration at 42 and 56 d.

Fig. 2. Plasma insulin-like growth factor (IGF )-I concentrations (mean ± SEM) in chicks (n = 6-8) fed soybean oil (SBO), butter + corn oil (BC), margarine + corn oil (MAC), or menhaden oil + corn oil (MEC) at 70 g/kg of the diet at 0, 14, 28 and 42 d of age.
[View Larger Version of this Image (16K GIF file)]

The mean concentration for IGF-I in liver tended to increase in all chicks except in the MAC group from 21 to 42 d of age (Table 4). Chicks fed the MEC diet had the highest IGF-I concentrations at 21 d. A similar trend of higher IGF-I concentration for chicks fed the MEC diet was observed in cortical bone and epiphyseal cartilage at 21 d, but no differences were observed between the dietary treatments for IGF-I in bone at 42 d. Chicks fed the SBO and MAC diets had a higher IGF-I concentration in cartilage compared with those fed the BC and MEC diets at 42 d. It is interesting that IGF-I concentration in liver, bone and cartilage increased in chicks consuming SBO from 21 to 42 d. The same was true for chicks fed BC except that IGF-I decreased in cartilage.

Table 4. Concentrations of insulin-like growth factor-I in chicks fed different lipids1

[View Table]

The hexosamine concentration in chick cortical bone was not influenced by the dietary treatments at 21 or 42 d; however, serum levels of hexosamines were highest in chicks fed the BC diet at 21 d (Table 5). The PLA2 activity in serum at 42 d was higher in chicks fed SBO and MEC [0.37 nmol/(min·mg protein)] compared with the activity in serum of those given BC and MAC (0.25). PLA2 activity in liver of 42-d-old chicks was not influenced by the dietary treatments [mean values ranged from 5.6 to 7.2 pmol/(min·mg protein)]. Chicks given the BC diet had the highest level of plasma vitamin E at 21 d and maintained a higher level compared with those fed MAC and MEC at 42 d (Table 5). The ash and calcium concentrations in tibia were not affected by the dietary treatments.

Table 5. Serum hexosamine and vitamin E levels and bone measurements in chicks fed different lipids1

[View Table]

In the second study, chicks given ABO had a significantly lower amount of 20:4(n-6) and reduced ex vivo PGE2 production in tibia compared with chicks fed SBO (Table 6). The ABO treatment also resulted in a higher concentration of IGF-I in bone and greater trabecular BFR.

Table 6. Body weights and tibia bone measurements from 16-d-old chicks fed soybean oil (SBO) or anhydrous butter oil (ABO)1

[View Table]

DISCUSSION

These studies demonstrated that dietary lipids modified the fatty acid composition of tibial cortical bone. Chicks given the BC diet maintained lower concentrations of 18:2(n-6) and 20:4(n-6) in bone polar lipids compared with the SBO group at 21 d. The BC diet, which contained moderate levels of PUFA but greater SAT, produced a higher ratio of SAT/PUFA in bone neutral lipids of chicks (2.86 at 21 d, and 2.61 at 42 d) compared with the ratio in those given SBO (1.2 at 21 d, and 1.0 at 42 d). In the second study, the concentrations of total (n-6) PUFA and 20:4(n-6) also were lower in cortical bone of chicks fed ABO compared with the values in the SBO group. The predominant effect produced by (n-3) PUFA in the MEC treatment group was a significant decrease in the concentration of 20:4(n-6), the precursor of PGE2 , and a concomitant increase in the amount of several (n-3) PUFA in bone polar and neutral lipids. In a study with rats, Alam et al. (1993) reported that feeding ethyl esters of (n-3) PUFA for 10 wk elevated the concentrations of 20:5(n-3) and 22:5(n-3) but lowered them for 20:4(n-6) in alveolar bone of the mandible.

Trans-fatty acids were incorporated into bone polar (1.5-6.7%) and neutral lipids (trace to 11.2%) in chicks fed the BC and MAC diets, and the uptake was dependent upon the level fed. In a previous study with chicks fed hydrogenated vegetable oil (44 wt% of t18:1), trans-18:1 fatty acids accumulated in liver and in epiphyseal cartilage of the tibia (Watkins et al. 1991).

Histomorphometric measurements made in cortical bone revealed that saturated fat significantly increased BFR in chicks at 21 d. Chicks given BC had higher values for periosteal BFR, total new BFR and intracortical porosity in cortical bone, and a higher level of circulating hexosamines compared with chicks fed the SBO and MEC diets. The higher BFR [158% (periosteal) and 168% (total new bone) of the SBO group] and level of serum hexosamines (component of bone matrix proteins) would reflect an increase in bone turnover (modeling and remodeling) in chicks fed the BC diet. These chicks also maintained the highest serum concentration of vitamin E, which was associated with greater trabecular BFR reported by our laboratory (Xu et al. 1995). The BC diet led to a higher SAT/PUFA ratio in bone and may spare serum vitamin E to enhance bone formation. A significant fat × vitamin E interaction was responsible for the higher trabecular BFR in chicks (Xu et al. 1995). A higher value for trabecular BFR was confirmed in chicks fed ABO in the second study. The fact that bone length, and bone ash and calcium contents were not different among the treatment groups suggests that the higher BFR in the BC group was perhaps accompanied by a corresponding increase in bone resorption that did not lead to a significant change in bone growth.

The plasma concentration of IGF-I increased from 14 to 56 d in all chicks, which corroborates earlier findings for growing chicks (Ballard et al. 1990). Chicks fed the MEC diet had the highest amount of IGF-I in plasma at 14 d, but at 28 d, the concentration in plasma of chicks fed the MAC diet was highest and then declined.

The IGF-I data for bone, cartilage and liver are more difficult to interpret because IGF-I was not consistently affected by diet; however, the IGF-I content of tissues tended to increase from 21 to 42 d in most groups. In contrast to bone, the higher concentration of IGF-I in cartilage of chicks fed BC compared with the value in those given SBO at 21 d might suggest a possible stimulatory effect of BC on early bone modeling; however, the IGF-I values in cartilage were reversed at 42 d for these two groups and yet no difference was observed in BFR. In the second study, the ABO diet resulted in a higher amount of IGF-I in tibial cortical bone, which coincided with the higher trabecular BFR. Even though these findings might suggest that dietary lipids influence the production of IGF-I, it is premature to explain the effects of dietary lipids on the action of IGF-I in skeletal tissues until measurements are performed for binding proteins and cell receptors that regulate its action. Furthermore, it is not known in what compartment of long bone (cortical and trabecular bone or epiphyseal cartilage) containing IGF-I that dominates bone formation. However, Pash and Canalis (1996) recently reported that PGE2 induced IGFBP-5 synthesis by a transcriptional mechanism in osteoblast-enriched cells from fetal rat calvaria. Our data and those of Pash and Canalis (1996) suggest that dietary lipids alter PGE2 production and may regulate the effects of IGF in bone by inducing IGFBP-5 synthesis. Future studies that examine dietary lipid effects on PGE2 and mRNA synthesis for IGF and IGFBP in bone are needed.

Existing evidence indicates that eicosanoids (especially PGE2 ) work in concert with growth factors and cytokines to regulate the local events of bone modeling (Norrdin et al. 1990, Raisz 1993). Further, the concentration of PGE2 produced locally in bone is critical; at moderate levels, it is stimulatory for bone formation but inhibitory at a higher level (Raisz and Fall 1990), and excess production of PGE2 is perhaps associated with bone pathology (Norrdin et al. 1990). In the present study, chicks given BC had a higher cortical BFR and lower concentration of 20:4(n-6) compared with chicks given SBO. A possible explanation for this response is that SBO led to an excess production of PGE2 from the higher 20:4(n-6) content in bone polar lipids to depress bone formation. The second study confirmed in the tibia that feeding ABO to chicks reduced 20:4(n-6) concentration, increased trabecular BFR, decreased ex vivo PGE2 production and elevated IGF-I concentration. Figure 3 illustrates the relationship between dietary (n-6) PUFA intake and modulation of locally produced PGE2 and IGF-I in bone, and the resulting effect on bone formation.

Fig. 3. Effects of (n-6) polyunsaturated fatty acids and saturated fat on the concentration of 20:4(n-6) and ex vivo prostaglandin E2 (PGE2 ) production in tibia. Panel A illustrates how soybean oil elevates both 20:4(n-6) and PGE2 in bone to reduce bone formation. Panel B shows how butter fat results in a moderate level of 20:4(n-6) and PGE2 in bone to support higher bone formation. The observations in chicks suggest that moderating PGE2 production in bone may increase the concentration or alter the action of insulin-like growth factor (IGF )-I in cartilage and bone to support greater bone formation.
[View Larger Version of this Image (14K GIF file)]

Relevant to the findings reported here is whether other eicosanoids besides PGE2 are produced in bone to maintain normal bone resorption and formation activities. Because 20:5(n-3) is the substrate for the biosynthesis of leukotriene B5 (LTB5 ), the enrichment of 20:5(n-3) observed in bone lipids found in this study could presumably increase the formation of LTB5 in bone. In mouse calvaria in vitro, LTB4 was found to stimulate bone resorption in a biphasic manner and to a greater extent than for PGE2 (Meghji et al. 1988). It is possible that LTB5 exhibits effects similar to PGE2 in bone, that is, stimulation of bone formation as well as bone resorption. The relationships between dietary PUFA and eicosanoid biosynthesis and level of mRNA for IGF-I in bone must be investigated.

In summary, the data demonstrated that dietary lipids altered the fatty acid composition of bone polar and neutral lipids. Notably, changes were observed in the concentration of PG precursors (20:4(n-6) and 20:5(n-3) and the ratio of SAT/PUFA. The increase in cortical bone formation in chicks fed butter suggests that the concentration of 20:4(n-6), PGE2 precursor, is important for proper bone modeling in the young because a moderate level of PGE2 stimulated bone formation, but a higher production of PGE2 was associated with reduced BFR. Indeed, the second study showed that saturated fat resulted in lowered bone 20:4(n-6) but raised IGF-I content, moderated ex vivo PGE2 production and increased trabecular BFR. In addition, a higher cortical BFR was accompanied by an increase in hexosamines in serum and IGF-I in epiphyseal cartilage of chicks fed butter. Although it is still unclear how dietary PUFA can alter the action of IGF-I in bone, recent research indicated that IGFBP-5 synthesis was induced by PGE2 in rat osteoblasts. Studies designed to characterize the effect of lipids on modulating PGE2 production and its subsequent effect on IGF-I expression in bone will explain important relationships between dietary fat and bone modeling in the young.

ACKNOWLEDGMENTS

The technical assistance of Donna Brocht and J. R. Burgess is greatly appreciated.

FOOTNOTES

1   Approved as Journal Paper Number 14361 of the Purdue Agricultural Experiment Station.
2   The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
3   To whom correspondence should be addressed.
4   Abbreviations used: ABO, anhydrous butter oil; BC, butter + corn oil; BFR, bone formation rate; BP, binding protein; FAME, fatty acid methyl esters; GLC, gas-liquid chromatography; IGF-I, insulin-like growth factor-I; IGFBP-3, insulin-like growth factor binding protein-3; LTB, leukotriene B; MAC, margarine + corn oil; MAR, mineral apposition rate; MEC, menhaden oil + corn oil; MONO, monounsaturated fatty acids; PGE2 , prostaglandin E2 ; PLA2 , phospholipase A2 ; PUFA, polyunsaturated fatty acids; SAT, saturated fatty acids; SBO, soybean oil; STD, standardized differences.

Manuscript received 6 August 1996. Initial reviews completed 8 October 1996. Revision accepted 17 February 1997.

LITERATURE CITED

0022-3166/97 $3.00 ©1997 American Society for Nutritional Sciences



This article has been cited by other articles:


Home page
 Poult. Sci.Home page
H. T. Baird, D. L. Eggett, and S. Fullmer
Varying Ratios of Omega-6:Omega-3 Fatty Acids on the Pre-and Postmortem Bone Mineral Density, Bone Ash, and Bone Breaking Strength of Laying Chickens
Poult. Sci., February 1, 2008; 87(2): 323 - 328.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
Y. H. Lin and N. Salem Jr.
Whole body distribution of deuterated linoleic and {alpha}-linolenic acids and their metabolites in the rat
J. Lipid Res., December 1, 2007; 48(12): 2709 - 2724.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
I. Platt, L. G. Rao, and A. El-Sohemy
Isomer-Specific Effects of Conjugated Linoleic Acid on Mineralized Bone Nodule Formation from Human Osteoblast-LikeCells
Experimental Biology and Medicine, February 1, 2007; 232(2): 246 - 252.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Poult. Res.Home page
J. J. Dibner, J. D. Richards, M. L. Kitchell, and M. A. Quiroz
Metabolic Challenges and Early Bone Development
J. Appl. Poult. Res., January 1, 2007; 16(1): 126 - 137.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
L. L. Burr, C. G. Taylor, and H. A. Weiler
Dietary Conjugated Linoleic Acid Does Not Adversely Affect Bone Mass in Obese fa/fa or Lean Zucker Rats.
Experimental Biology and Medicine, November 1, 2006; 231(10): 1602 - 1609.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. M. Rahman, A. Bhattacharya, and G. Fernandes
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling
J. Lipid Res., August 1, 2006; 47(8): 1739 - 1748.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
R. A. Brownbill, M. Petrosian, and J. Z. Ilich
Association between Dietary Conjugated Linoleic Acid and Bone Mineral Density in Postmenopausal Women
J. Am. Coll. Nutr., June 1, 2005; 24(3): 177 - 181.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. C. Mollard, M. E. Gillam, T. M. Wood, C. G. Taylor, and H. A. Weiler
(n-3) Fatty Acids Reduce the Release of Prostaglandin E2 from Bone but Do Not Affect Bone Mass in Obese (fa/fa) and Lean Zucker Rats
J. Nutr., March 1, 2005; 135(3): 499 - 504.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. C. Mollard, H. R. Kovacs, S. C. Fitzpatrick-Wong, and H. A. Weiler
Low Levels of Dietary Arachidonic and Docosahexaenoic Acids Improve Bone Mass in Neonatal Piglets, but Higher Levels Provide No Benefit
J. Nutr., March 1, 2005; 135(3): 505 - 512.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. Reinwald, Y. Li, T. Moriguchi, N. Salem Jr., and B. A. Watkins
Repletion with (n-3) Fatty Acids Reverses Bone Structural Deficits in (n-3)-Deficient Rats
J. Nutr., February 1, 2004; 134(2): 388 - 394.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. L Blanaru, J. R Kohut, S. C Fitzpatrick-Wong, and H. A Weiler
Dose response of bone mass to dietary arachidonic acid in piglets fed cow milk-based formula
Am. J. Clinical Nutrition, January 1, 2004; 79(1): 139 - 147.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. A. Weiler and S. C. Fitzpatrick-Wong
Modulation of Essential (n-6):(n-3) Fatty Acid Ratios Alters Fatty Acid Status but Not Bone Mass in Piglets
J. Nutr., September 1, 2002; 132(9): 2667 - 2672.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
B. A. Watkins, Y. Li, and M. F. Seifert
Nutraceutical Fatty Acids as Biochemical and Molecular Modulators of Skeletal Biology
J. Am. Coll. Nutr., October 1, 2001; 20(90005): 410S - 416.
[Abstract] [Full Text]

Home page
 Exp. Biol. Med.Home page
B. A. Watkins, Y. Li, H. E. Lippman, and M. F. Seifert
Omega-3 Polyunsaturated Fatty Acids and Skeletal Health
Experimental Biology and Medicine, June 1, 2001; 226(6): 485 - 497.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
B. A. Watkins, Y. Li, K. G. D. Allen, W. E. Hoffmann, and M. F. Seifert
Dietary Ratio of (n-6)/(n-3) Polyunsaturated Fatty Acids Alters the Fatty Acid Composition of Bone Compartments and Biomarkers of Bone Formation in Rats
J. Nutr., September 1, 2000; 130(9): 2274 - 2284.
[Abstract] [Full Text]

Home page
 J. Am. Coll. Nutr.Home page
B. A. Watkins and M. F. Seifert
Conjugated Linoleic Acid and Bone Biology
J. Am. Coll. Nutr., August 1, 2000; 19(4): 478S - 486.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
K. D. Hankenson, B. A. Watkins, I. A. Schoenlein, K. G. D. Allen, and J. J. Turek
Omega-3 Fatty Acids Enhance Ligament Fibroblast Collagen Formation in Association with Changes in Interleukin-6 Production
Experimental Biology and Medicine, January 1, 2000; 223(1): 88 - 95.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
S. M Innis and D J. King
trans Fatty acids in human milk are inversely associated with concentrations of essential all-cis n-6 and n-3 fatty acids and determine trans, but not n-6 and n-3, fatty acids in plasma lipids of breast-fed infants
Am. J. Clinical Nutrition, September 1, 1999; 70(3): 383 - 390.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. G. Hayek, S. N. Han, D. Wu, B. A. Watkins, M. Meydani, J. L. Dorsey, D. E. Smith, and S. N. Meydani
Dietary Conjugated Linoleic Acid Influences the Immune Response of Young and Old C57BL/6NCrlBR Mice.
J. Nutr., January 1, 1999; 129(1): 32 - 38.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watkins, B. A.
Right arrow Articles by Seifert, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watkins, B. A.
Right arrow Articles by Seifert, M. F.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 1997 by American Society for Nutrition